Pembrolizumab and Trifluridine/Tipiracil With Previously Treated Advanced Gastric Cancer
Clinical trial NCT05508737 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05508737
- Sponsor
- Yonsei University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2025-11-02
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.